Patent Applications published on May 18, 2023 - page 4

#901
US20230149369A1
Human necessities

Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease

#902
US20230149370A1
Human necessities

USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY

#903
US20230149371A1
Human necessities

TETRAZOLE DERIVATIVES

#904 ✅ Patent 11,883,385 granted on 2024-01-30
US20230149372A1
Human necessities

Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome

#905
US20230149373A1
Human necessities

USE OF BROMODOMAIN INHIBITORS FOR TREATMENT OF HUNTINGTON'S DISEASE

#906
US20230149374A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

#907 ✅ Patent 12,226,407 granted on 2025-02-18
US20230149375A1
Human necessities

Aerosol pirfenidone and pyridone analog compounds and uses thereof

#908
US20230149376A1
Human necessities

TRITERPENOID ANTIFUNGALS FOR THE TREATMENT OR PREVENTION OF PNEUMOCYSTIS SPP. PNEUMONIA

#909
US20230149377A1
Human necessities

PHARMACEUTICAL METHODS

#910
US20230149378A1
Human necessities

Aminothiolester compounds or pharmaceutically acceptable salts thereof, for use for the treatment of cancer

#911
US20230149379A1
Human necessities

COMBINATION THERAPY FOR ACUTE MYELOID LEUKEMIA

#912 ✅ Patent 11,986,469 granted on 2024-05-21
US20230149380A1
Human necessities

Methods of treating prostate cancer

#913
US20230149381A1
Human necessities

BREAST CANCER THERAPEUTIC AGENT

#914 ✅ Patent 12,295,947 granted on 2025-05-13
US20230149382A1
Human necessities

Tetrahydroquinoline derivatives as P2X7 receptor antagonists

#915
US20230149383A1
Human necessities

QUINOLINE COMPOUNDS FOR TREATING LUNG, LIVER, AND KIDNEY DISEASES, DISORDERS, OR CONDITIONS

#916
US20230149384A1
Human necessities

Method of Treating Cancer and Bone Cancer Pain

#917
US20230149385A1
Human necessities

COMPOSITIONS AND USES THEREOF

#918
US20230149387A1
Human necessities

TREATMENTS

#919
US20230149388A1
Human necessities

OPIOID ANTAGONIST FORMULATIONS

#920
US20230149389A1
Human necessities

METHODS OF REDUCING MORTALITY IN SUBJECTS SUFFERING FROM AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONE

#921
US20230149390A1
Human necessities

COMPOSITIONS FOR OPIATE AND OPIOID PREVENTION AND REVERSAL, AND METHODS OF THEIR USE

#922
US20230149391A1
Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AND PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH VIRAL INFECTIONS

#923
US20230149392A1
Human necessities

TREATMENT OF MAJOR DEPRESSIVE DISORDER

#924
US20230149393A1
Human necessities

INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONS

#925 ✅ Patent 12,295,952 granted on 2025-05-13
US20230149394A1
Human necessities

Methods of treating heart failure with cardiac sarcomere activators

#926
US20230149395A1
Human necessities

METHODS OF TREATING RELAPSING MULTIPLE SCLEROSIS USING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

#927
US20230149396A1
Human necessities

ORAL SOLID PREPARATIONS

#928
US20230149397A1
Human necessities

Combination Therapy with AXL Inhibitor and Immune Checkpoint Modulator or Oncolytic Virus

#929
US20230149398A1
Human necessities

TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING IMIDAZO[1,2-B]PYRIDAZINE COMPOUNDS

#930
US20230149399A1
Human necessities

TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES

#931
US20230149400A1
Human necessities

METHODS AND COMPOSITIONSFOR TREATING VIRAL INFECTIONS

#932
US20230149401A1
Human necessities

FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS

#933
US20230149402A1
Human necessities

SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF

#934 ✅ Patent 12,263,168 granted on 2025-04-01
US20230149403A1
Human necessities

Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

#935 ✅ Patent 12,064,432 granted on 2024-08-20
US20230149404A1
Human necessities

Treatment of adipocytes

#936
US20230149405A1
Human necessities

TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDREN

#937 ✅ Patent 12,364,697 granted on 2025-07-22
US20230149406A1
Human necessities

G1T38 SUPERIOR DOSAGE REGIMES

#938
US20230149407A1
Human necessities

Methods of Treating Coronavirus Disease 2019

#939
US20230149408A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#940
US20230149409A1
Human necessities

TREATMENT OF HUMAN PAPILLOMAVIRUS-ASSOCIATED CANCERS BY PD-L1 INHIBITORS

#941
US20230149410A1
Human necessities

TREATMENT OF CONDITIONS ASSOCIATED WITH THYROID HORMONE

#942
US20230149411A1
Human necessities

ORAL CAPSULE AND PREPARATION METHOD THEREFOR

#943
US20230149412A1
Human necessities

Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity

#944
US20230149413A1
Human necessities

HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY

#945
US20230149414A1
Human necessities

COMPOUNDS AND USES THEREOF

#946
US20230149415A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER

#947
US20230149416A1
Human necessities

PIPERIDINYLPYRAZINE-CARBOXAMIDE COMPOUNDS FOR TREATING AND PREVENTING CANCER AND FOR DEGRADING BTK

#948 ✅ Patent 12,076,325 granted on 2024-09-03
US20230149417A1
Human necessities

Prophylactic or therapeutic agent for hypoxic injury, ischaemia-reperfusion injury and inflammation, cell protection agent for transplantation, and bio-preservation agent

#949
US20230149418A1
Human necessities

METHODS AND SYNERGIC COMPOSITIONS FOR TREATING VIRAL INFECTIONS

#950
US20230149419A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING NEUROINFLAMMATORY DISEASES, COMPRISING CHLORPROMAZINE

#951
US20230149420A1
Human necessities

ANTI-INFLAMMATORY IMMUNOENHANCER

#952
US20230149421A1
Human necessities

MEDICAMENT FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME OR INFLAMMATORY BOWEL DISEASE

#953
US20230149422A1
Human necessities

COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS, 17-HDHA AND 18-HEPE AND METHODS OF USING SAME

#954
US20230149423A1
Human necessities

COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS, 17-HDHA AND 18-HEPE AND METHODS OF USING SAME

#955
US20230149424A1
Human necessities

NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS

#956
US20230149425A1
Human necessities

PROCESS AND THERAPEUTIC COMPOSITION FOR TREATING AND PREVENTING SEVERE INJECTION SITE REACTIONS

#957
US20230149426A1
Human necessities

Nutritional Intervention for Improving Muscular Function and Strength

#958
US20230149427A1
Human necessities

COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE

#959
US20230149428A1
Human necessities

METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS

#960 ✅ Patent 12,083,135 granted on 2024-09-10
US20230149429A1
Human necessities

Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia

#961
US20230149430A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTION-INDUCED CARDIOMYOPATHY

#962
US20230149431A1
Human necessities

COMPOSITION AND METHOD FOR PRODUCING A COMPOSITION

#963
US20230149432A1
Human necessities

Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection

#964
US20230149433A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES

#965
US20230149434A1
Human necessities

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#966
US20230149435A1
Human necessities

USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON PAIN INDUCED BY PHYSICAL ACTIVITY AND CORRESPONDING COMPOSITIONS

#967
US20230149436A1
Human necessities

COMBINATION THERAPY

#968
US20230149437A1
Human necessities

METHODS FOR ENHANCING VASCULAR DENSITY

#969
US20230149438A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PREKALLIKREIN-ASSOCIATED CONDITIONS

#970
US20230149439A1
Human necessities

RHO-ADRP GENE EDITING-BASED METHODS AND COMPOSITIONS

#971
US20230149440A1
Human necessities

OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID

#972
US20230149441A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR RNA VIRUS INDUCED INFECTIONS AND DISORDERS

#973
US20230149442A1
Human necessities

Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel and Uses Therefor

#974
US20230149443A1
Human necessities

CUSTOMIZABLE DOSAGE FORMS CONTAINING SIMETHICONE

#975
US20230149444A1
Human necessities

HYPOCHLOROUS ACID SOLUTIONS AND METHODS OF USE

#976
US20230149445A1
Human necessities

OXIDATIVE STRESS INHIBITOR AND ANTIOXIDANT AGENT

#977 ✅ Patent 12,029,756 granted on 2024-07-09
US20230149446A1
Human necessities

Intravenous physiological solution to optimize fluid therapy in patients

#978
US20230149447A1
Human necessities

KIT AND METHOD FOR PROVIDING ADDITIONAL DEFENSE AGAINST ALL CORONA VIRUS STRAINS

#979
US20230149448A1
Human necessities

METHODS FOR PREVENTING AND TREATING RESPIRATORY INFECTIONS VIA MODIFICATION OF VIRUS RECEPTOR BINDING DOMAINS USING HYPOHALOUS ACIDS

#980
US20230149449A1
Human necessities

ION CAPTURE COMPOSITION FOR INGESTION

#981
US20230149450A1
Human necessities

PREPARATION FOR MAGNETIZING KIDNEY STONES AND KIDNEY STONE FRAGMENTS AND KIT FOR REMOVING KIDNEY STONES AND KIDNEY STONE FRAGMENTS

#982 ✅ Patent 12,201,649 granted on 2025-01-21
US20230149451A1
Human necessities

Pharmaceutical composition comprising oxidizable biphenol and manganese porphyrin, and method of using the same

#983
US20230149452A1
Human necessities

STRUCTURALLY DEFINED, BETTER TOLERATED, ORALLY ADMINSTERED, PROCESSED ARSENOLITE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USES THEREOF

#984
US20230149453A1
Human necessities

Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals

#985
US20230149454A1
Human necessities

ANTISEPTIC APPLICATIONS OF METAL NANOPARTICLE AGGLOMERATES

#986
US20230149455A1
Human necessities

ALKALINE WATER COMPOSITIONS AND USES THEREOF

#987
US20230149456A1
Human necessities

NANOPARTICLE-LOADED SILICIFIED CELLS, METHODS OF MAKING, AND METHODS OF USE

#988
US20230149457A1
Human necessities

LONG LIVED T CELLS FOR TREATING HIV INFECTION

#989 ✅ Patent 11,944,647 granted on 2024-04-02
US20230149458A1
Human necessities

Articles of manufacture and methods for treatment using adoptive cell therapy

#990
US20230149459A1
Human necessities

V DELTA1+ T CELLS FOR THE TREATMENT OF MYELOID MALIGNANCIES

#991
US20230149460A1
Human necessities

METHODS FOR GENERATING ENGINEERED MEMORY-LIKE NK CELLS AND COMPOSITIONS THEREOF

#992
US20230149461A1
Human necessities

COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN ALLOGENEIC CELL THERAPY

#993
US20230149462A1
Human necessities

METHODS AND USES RELATED TO CELL THERAPY ENGINEERED WITH A CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MATURATION ANTIGEN

#994
US20230149463A1
Human necessities

METHOD OF EXPANDING AND GENERATING A POPULATION OF CYTOKINE-INDUCED KILLER CELLS FROM PERIPHERAL BLOOD

#995
US20230149464A1
Human necessities

FEEDER FREE CELL CULTURE METHODS FOR EXPANDING NATURAL KILLER CELL PREPARATIONS

#996
US20230149465A1
Human necessities

GENETICALLY MODIFIED IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR AND HAVING REDUCED PROINFLAMMATORY CYTOKINE SIGNALING

#997
US20230149466A1
Human necessities

IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING CANCER FIBROBLASTS

#998
US20230149467A1
Human necessities

PLATELET DERIVATIVE COMPOSITIONS, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS

#999
US20230149468A1
Human necessities

PLATELET DERIVED EXTRACELLULAR VESICLES

#1000
US20230149469A1
Human necessities

WOUND HEALING AND TISSUE ENGINEERING

#1001
US20230149470A1
Human necessities

PLACENTA-DERIVED MULTIPOTENT STEM CELLS

#1002
US20230149471A1
Human necessities

COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES

#1003 ✅ Patent 12,128,073 granted on 2024-10-29
US20230149472A1
Human necessities

Canine-specific therapeutic compositions and methods of use

#1004
US20230149473A1
Human necessities

COMPOSITION COMPRISING CORD BLOOD PLATELET RICH PLASMA (CB-PRP) AND USES THEROF

#1005 ✅ Patent 11,903,978 granted on 2024-02-20
US20230149474A1
Human necessities

Non-winterized, standardized marine source oil products and methods of making thereof

#1006
US20230149475A1
Human necessities

COMPOSITION FOR PREVENTING, IMPROVING, OR TREATING SARCOPENIA, COMPRISING TENEBRIO MOLITOR LARVAL PROTEIN OR HYDROLYSATE THEREOF AS ACTIVE INGREDIENT

#1007
US20230149476A1
Human necessities

BOWEL MOVEMENT IMPROVING COMPOSITION COMPRISING TENEBRIONIDAE LARVA EXTRACT

#1008
US20230149477A1
Human necessities

METHODS OF IMPROVING HEALTH OF YOUNG RUMINANTS

#1009
US20230149478A1
Human necessities

COMPOSITIONS AND METHODS FOR DIABETES TREATMENT

#1010
US20230149479A1
Human necessities

COMPOSITIONS AND METHODS COMPRISING CLOSTRIDIUM BUTYRICUM FOR THE TREATMENT OF CANCER

#1011 ✅ Patent 11,730,779 granted on 2023-08-22
US20230149480A1
Human necessities

Lactic acid bacterial composition for treating or preventing jaundice

#1012
US20230149481A1
Human necessities

COMBINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE

#1013
US20230149482A1
Human necessities

COMPOSITION FOR IMPROVING GUT MICROBIOTA

#1014
US20230149483A1
Human necessities

SHORT-CHAIN FATTY ACID USE TO MITIGATE ANTIMICROBIAL RESISTANCE AND VIRULENCE GENE TRANSFER IN THE GUT

#1015
US20230149484A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTIC AND PREBIOTIC TO TREAT STUNTING

#1016
US20230149485A1
Human necessities

ENGINEERED ONCOLYTIC ADENOVIRUS

#1017 ✅ Patent 11,865,148 granted on 2024-01-09
US20230149486A1
Human necessities

Methods of delivering transgenes to the eye

#1018
US20230149487A1
Human necessities

DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT

#1019
US20230149488A1
Human necessities

Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity

#1020
US20230149489A1
Human necessities

ANTIBACTERIAL MOUTHRINSE COMPOSITION COMPRISING PROBOSCIDEA JUSSIEUI

#1021
US20230149490A1
Human necessities

NOVEL COMPOSITION COMPRISING EDELWEISS-DERIVED EXOSOME AS ACTIVE INGREDIENT

#1022
US20230149491A1
Human necessities

MANGOSTEEN PERICARP EXTRACTAND PROCESS FOR ITS PREPARATION THEREOF

#1023
US20230149492A1
Human necessities

HERBAL COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING SARS-COV-2 VIRUS INFECTION

#1024
US20230149493A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING COVID-19 AND SYMPTOMS THEREOF

#1025
US20230149494A1
Human necessities

HERBAL COMPOSITION, PREPARATION METHOD THEREOF AND METHOD FOR PREVENTING OR TREATING RESPIRATORY DISORDER BY ADMINISTERING THE SAME

#1026
US20230149495A1
Human necessities

MODULATION OF NCRNAS, LYMPHOCYTES, NEUTROPHILS, INFLAMMASOMES AND P53

#1027
US20230149496A1
Human necessities

BLOCKING A PATHOGEN FROM EXPRESSING A VIRULENCE FACTOR

#1028
US20230149497A1
Human necessities

GRAPE SKIN FOR USE IN THE TREATMENT OF DYSBIOSIS

#1029 ✅ Patent 12,109,246 granted on 2024-10-08
US20230149498A1
Human necessities

Composition for the treatment and/or prevention of lower urinary tract symptoms

#1030 ✅ Patent 11,857,594 granted on 2024-01-02
US20230149499A1
Human necessities

Curcumin compositions and methods of use as an NK3 antagonist

#1031 ✅ Patent 11,951,147 granted on 2024-04-09
US20230149500A1
Human necessities

SMAC mimetic

#1032
US20230149501A1
Human necessities

METHODS FOR REDUCING OXIDATIVE DAMAGE

#1033
US20230149502A1
Human necessities

CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS

#1034
US20230149503A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DYSREGULATED WOUND HEALING

#1035
US20230149504A1
Human necessities

ALISPORIVIR FOR USE IN HUMAN VIRAL INFECTIONS

#1036 ✅ Patent 11,883,461 granted on 2024-01-30
US20230149505A1
Human necessities

HMGB1 antagonist treatment of severe sepsis

#1037
US20230149506A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING RETINAL DYSTROPHIES, COMPRISING NKX3.2 AND FRAGMENT THEREOF AS ACTIVE INGREDIENTS

#1038
US20230149507A1
Human necessities

TREATMENT OF ALT CANCERS

#1039
US20230149508A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS

#1040
US20230149509A1
Human necessities

IL15/IL15R ALPHA HETERODIMERIC FC-FUSION PROTEINS FOR THE TREATMENT OF CANCER

#1041
US20230149510A1
Human necessities

METHOD FOR ALLEVIATING ARTHRITIS USING EPIDERMAL GROWTH FACTOR

#1042
US20230149511A1
Human necessities

TREATING AUTOIMMUNE DISEASES WITH GENETICALLY MODIFIED CELLS

#1043
US20230149512A1
Human necessities

LOW DOSE IL-2 FOR TREATING AUTOIMMUNE-RELATED OR INFLAMMATORY DISORDERS

#1044
US20230149513A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR CORNEAL TISSUE REPAIR BY INSULIN NANOSYSTEM AND USE THEREOF

#1045
US20230149514A1
Human necessities

CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION

#1046
US20230149515A1
Human necessities

INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ORAL ADMINISTRATION OF LACTOFERRIN AND USES THEREOF

#1047
US20230149516A1
Human necessities

USE OF PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR THERAPEUTIC PURPOSE

#1048 ✅ Patent 12,161,699 granted on 2024-12-10
US20230149517A1
Human necessities

Urate oxidase-albumin conjugate, preparation method thereof, and use thereof

#1049
US20230149518A1
Human necessities

COMPOSITIONS AND METHODS FOR DISRUPTING BIOFILM FORMATION AND MAINTENANCE

#1050 ✅ Patent 12,076,377 granted on 2024-09-03
US20230149519A1
Human necessities

Variant sulfatase enzymes with enhanced properties

#1051 ✅ Patent 11,957,741 granted on 2024-04-16
US20230149520A1
Human necessities

Long lasting effect of new botulinum toxin formulations

#1052
US20230149521A1
Human necessities

METHODS OF TREATING VIRAL INFECTIONS USING ARGINASE

#1053
US20230149522A1
Human necessities

POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS

#1054
US20230149523A1
Human necessities

TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS

#1055
US20230149524A1
Human necessities

IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF

#1056
US20230149525A1
Human necessities

IMMUNOGENIC TREATMENT OF CANCER

#1057
US20230149526A1
Human necessities

COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF

#1058
US20230149527A1
Human necessities

Virus-like particles containing CST1 protein and toxoplasma vaccine using same

#1059
US20230149528A1
Human necessities

DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE O

#1060
US20230149529A1
Human necessities

FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN, VACCINE COMPOSITION, PREPARATION METHOD, AND USE THEREOF

#1061
US20230149530A1
Human necessities

INFLUENZA VACCINES

#1062
US20230149531A1
Human necessities

Suprastructure Comprising Modified Influenza Hemagglutinin With Reduced Interaction With Sialic Acid

#1063
US20230149532A1
Human necessities

VACCINES FORMED BY VIRUS AND ANTIGEN CONJUGATION

#1064
US20230149533A1
Human necessities

SARS-COV-2 MUCOSAL VACCINE COMPOSITION, PREPARATION AND USE THEREOF

#1065
US20230149534A1
Human necessities

HAPTENIZED CORONAVIRUS SPIKE PROTEINS

#1066
US20230149535A1
Human necessities

VACCINES FOR CORONAVIRUS AND METHODS OF USING THE SAME

#1067
US20230149536A1
Human necessities

COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS INFECTIONS

#1068
US20230149537A1
Human necessities

VACCINES, ADJUVANTS, AND METHODS OF GENERATING AN IMMUNE RESPONSE

#1069 ✅ Patent 12,201,683 granted on 2025-01-21
US20230149538A1
Human necessities

Methods for preventing dengue and hepatitis a

#1070
US20230149539A1
Human necessities

THERAPEUTIC TREATMENT KIT FOR ALLERGIES BASED ON DNA PROFILES

#1071
US20230149540A1
Human necessities

VACCINE PLATFORM FOR THE INDUCTION OF SYSTEMIC IMMUNE RESPONSES

#1072
US20230149541A1
Human necessities

USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING MONOCYTE IMMUNE RESPONSE

#1073
US20230149542A1
Human necessities

NUTRITIONAL FORMULATIONS FOR MODULATING RESPIRATORY-INDUCED CYTOKINES

#1074
US20230149543A1
Human necessities

COMBINATION TREATMENT FOR CANCER BASED UPON AN ICOS ANTBODY AND A PD-L1 ANTIBODY TGF-BETS-RECEPTOR FUSION PROTEIN

#1075 ✅ Patent 12,290,565 granted on 2025-05-06
US20230149544A1
Human necessities

Methods of using anti-PSGL-1 antibodies in combination with JAK inhibitors to treat T-cell mediated inflammatory diseases or cancers

#1076
US20230149545A1
Human necessities

Method and kit for treating skin infections

#1077
US20230149546A1
Human necessities

PHOTOSENSITIZER CONJUGATED GOLD NANOPARTICLES FOR RADIOTHERAPY ENHANCEMENT

#1078
US20230149547A1
Human necessities

REDUCED CALORIC INTAKE AND IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

#1079 ✅ Patent 11,833,205 granted on 2023-12-05
US20230149548A1
Human necessities

Kaolinite composite diagnostic and therapeutic agent and preparation method and use thereof

#1080
US20230149549A1
Human necessities

SMARCA DEGRADERS AND USES THEREOF

#1081
US20230149550A1
Human necessities

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

#1082
US20230149551A1
Human necessities

ARGININE METHYLTRANSFERASE 5 (PRMT5) DEGRADERS AND USES THEREOF

#1083 ✅ Patent 11,964,022 granted on 2024-04-23
US20230149552A1
Human necessities

Small molecule binders of the oncogenic fusion transcription factor PAX3-FOXO1

#1084
US20230149553A1
Human necessities

LIQUID PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED PRODRUGS OF ADRENOMEDULLIN AND USE

#1085
US20230149554A1
Human necessities

TARGETED DEGRADATION OF THE ONCOGENIC MICRORNA 17-92 CLUSTER BY STRUCTURE-TARGETING LIGANDS

#1086
US20230149555A1
Human necessities

MEDICAMENT FOR KILLING TUMOR CELLS

#1087
US20230149556A1
Human necessities

COMBINATION THERAPY

#1088
US20230149557A1
Human necessities

ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND CETUXIMAB

#1089
US20230149558A1
Human necessities

DUOCARMYCIN DERIVATIVE AND USE THEREOF

#1090
US20230149559A1
Human necessities

SUPRAMOLECULAR CELL-BASED CARRIER, DRUG LOADING SYSTEM AND ITS PREPARATION METHOD

#1091
US20230149560A1
Human necessities

LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF

#1092
US20230149561A1
Human necessities

Functionalized Nanoparticles and Their Use in Treating Bacterial Infections

#1093
US20230149562A1
Human necessities

CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY

#1094
US20230149563A1
Human necessities

COMPOSITIONS AND METHODS FOR EXPRESSING FACTOR IX FOR HEMOPHILIA B THERAPY

#1095
US20230149564A1
Human necessities

AAV-NAGLU VECTORS FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIB

#1096
US20230149565A1
Human necessities

DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT OF USH1B

#1097
US20230149566A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING MACULAR DYSTROPHY

#1098
US20230149567A1
Human necessities

MECHANICAL OPENING OF LIPID BILAYERS BY MOLECULAR NANOMACHINES

#1099 ✅ Patent 12,064,487 granted on 2024-08-20
US20230149568A1
Human necessities

Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process

#1100
US20230149569A1
Human necessities

MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY

#1101
US20230149570A1
Human necessities

METAL NUCLIDE-LOADED CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF

#1102
US20230149571A1
Human necessities

Apparatus and Methods for Inactivating Bacteria on Surfaces and Mammalian Tissue

#1103 ✅ Patent 12,171,890 granted on 2024-12-24
US20230149572A1
Human necessities

Disease protection sheets

#1104
US20230149573A1
Human necessities

APPARATUS FOR PROVIDING ANTIBACTERIAL FILM

#1105
US20230149574A1
Human necessities

Method and Apparatus for Sanitization of Hand Coverings

#1106 ✅ Patent 12,370,278 granted on 2025-07-29
US20230149575A1
Human necessities

PROPORTIONALITY OF DISTRIBUTED ILLUMINATION WITH ADAPTIVE MULTIVECTOR DELIVERY SYSTEM

#1107 ✅ Patent 11,964,066 granted on 2024-04-23
US20230149576A1
Human necessities

Unified airflow system for ultraviolet disinfection devices

#1108 ✅ Patent 12,329,867 granted on 2025-06-17
US20230149577A1
Human necessities

METHODS AND SYSTEMS FOR TREATMENT OF VEHICLE SURFACES AND AIR

#1109
US20230149578A1
Human necessities

INACTIVATION DEVICE AND INACTIVATION METHOD

#1110
US20230149579A1
Human necessities

SYSTEM AND METHOD FOR A SAFE ULTRAVIOLET DISINFECTANT DEVICE USING HUMAN PROXIMITY SENSING

#1111
US20230149580A1
Human necessities

SELF-STERILISING DOOR LEVER HANDLE ASSEMBLY

#1112
US20230149581A1
Human necessities

RADIATION-BASED DISINFECTION SYSTEM AND METHOD

#1113
US20230149582A1
Human necessities

SYSTEM AND METHOD FOR DISINFECTING A VOLUME IN SPACE

#1114
US20230149583A1
Human necessities

Mobile Disinfection Apparatuses Having Visual Marker Detection Systems And Methods Of Their Use

#1115 ✅ Patent 12,178,934 granted on 2024-12-31
US20230149584A1
Human necessities

Medical instrument sterilization backer card

#1116
US20230149585A1
Human necessities

PERFUME HOLDING MEMBER AND FRAGRANCE PROVIDING DEVICE

#1117
US20230149586A1
Human necessities

AIR QUALITY MONITOR WITH INTEGRATED AIR FRESHENER

#1118 ✅ Patent 12,251,501 granted on 2025-03-18
US20230149587A1
Human necessities

Scent retaining structure, method of manufacturing the scent retaining structure, and scent providing device

#1119
US20230149588A1
Human necessities

COMPRESSED GAS AEROSOLS WITH ENHANCED INTENSITY AND LONGEVITY OF ACTIVES

#1120
US20230149589A1
Human necessities

Air Filter Device Incorporating Anti-Microbial Filter Media

#1121 ✅ Patent 11,839,704 granted on 2023-12-12
US20230149590A1
Human necessities

Adaptive multivector illumination delivery system

#1122 ✅ Patent 12,109,341 granted on 2024-10-08
US20230149591A1
Human necessities

Discharge device

#1123
US20230149592A1
Human necessities

HEMOSTATIC DEVICES

#1124
US20230149593A1
Human necessities

WOUND DRESSING ARTICLES MADE OF ARRAYS OF MICROSCOPIC NEEDLES OBTAINED FROM EXOSKELETONS OF CRUSTACEANS AND METHOD OF MANUFACTURING THE SAME

#1125
US20230149594A1
Human necessities

ELECTRICALLY SWITCHABLE ADHESIVES FOR APPLICATION ON SKIN AND RELATED PRODUCTS AND USES

#1126
US20230149595A1
Human necessities

IMPLANTABLE OBJECTS, GUIDING DEVICES, AND METHODS OF USE THEREOF

#1127
US20230149596A1
Human necessities

MULTI-USE HEMOSTATIC COMPOSITION AND METHOD FOR PRODUCING SAME

#1128 ✅ Patent 12,115,274 granted on 2024-10-15
US20230149597A1
Human necessities

Porous tricalcium phosphate material, method for bone healing using the same, and manufacturing method thereof

#1129 ✅ Patent 11,738,113 granted on 2023-08-29
US20230149598A1
Human necessities

Sterilization of self-assembling peptides by irradiation

#1130 ✅ Patent 11,738,114 granted on 2023-08-29
US20230149599A1
Human necessities

Sterilization of self-assembling peptides by irradiation

#1131
US20230149600A1
Human necessities

COLLAGEN-BASED DEVICE HAVING ANTIFUNGAL PROPERTIES

#1132 ✅ Patent 12,036,337 granted on 2024-07-16
US20230149601A1
Human necessities

Implantable scaffolds for treatment of sinusitis

#1133 ✅ Patent 11,730,864 granted on 2023-08-22
US20230149602A1
Human necessities

Drug coated balloon catheters for nonvascular strictures

#1134
US20230149603A1
Human necessities

DRUG-RELEASING POLYMER COMPOSITION AND DEVICE

#1135
US20230149604A1
Human necessities

POLYPEPTIDE MONOLAYER WITH HIGH POTENTIAL AND SUPER-HYDROPHILICITY, AND PREPARATION METHOD AND APPLICATION THEREOF

#1136
US20230149605A1
Human necessities

NANOBARRIER AND METHOD OF REGULATING MACROPHAGE ADHESION AND POLARIZATION USING THE SAME

#1137 ✅ Patent 11,850,341 granted on 2023-12-26
US20230149606A1
Human necessities

Flow balancing devices, methods, and systems

#1138 ✅ Patent 11,944,733 granted on 2024-04-02
US20230149607A1
Human necessities

Sodium and bicarbonate control

#1139
US20230149608A1
Human necessities

FLUID SENSOR SYSTEM

#1140
US20230149609A1
Human necessities

Holder for Lines of a Blood Treatment Apparatus

#1141
US20230149610A1
Human necessities

PERITONEAL DIALYSIS CYCLER HAVING DISINFECTION

#1142 ✅ Patent 12,070,540 granted on 2024-08-27
US20230149611A1
Human necessities

Wetness detector with integrated inertial measurement unit configured for use in a dialysis system

#1143
US20230149612A1
Human necessities

Self-Sealing Fluid Connectors

#1144
US20230149613A1
Human necessities

DEVICES AND METHODS FOR TREATING OR PREVENTING CYTOKINE RELEASE SYNDROME AND TUMOR LYSIS SYNDROME

#1145
US20230149614A1
Human necessities

METHOD OF REMOVING HARMFUL SUBSTANCES IN BLOOD

#1146 ✅ Patent 11,857,714 granted on 2024-01-02
US20230149615A1
Human necessities

Systems and methods for monitoring and controlling fluid balance during a biological fluid procedure

#1147 ✅ Patent 11,975,133 granted on 2024-05-07
US20230149616A1
Human necessities

Easily movable blood purification systems

#1148
US20230149617A1
Human necessities

METHODS OF TREATING CONDITIONS

#1149
US20230149618A1
Human necessities

INSERT FOR A CENTRIFUGE ROTOR

#1150
US20230149619A1
Human necessities

HANDHELD PORTABLE ORAL ASPIRATOR

#1151 ✅ Patent 12,239,776 granted on 2025-03-04
US20230149620A1
Human necessities

Sensing cannula systems

#1152 ✅ Patent 11,944,741 granted on 2024-04-02
US20230149621A1
Human necessities

Medical treatment systems and related methods thereof

#1153
US20230149622A1
Human necessities

METHOD FOR PRODUCING A DRIP CHAMBER, DRIP CHAMBER, INFUSION SYSTEM OR TRANSFUSION SYSTEM

#1154
US20230149623A1
Human necessities

INFUSION PUMPS

#1155 ✅ Patent 12,102,793 granted on 2024-10-01
US20230149624A1
Human necessities

System and method for syringe plunger engagement with an injector

#1156 ✅ Patent 11,883,628 granted on 2024-01-30
US20230149625A1
Human necessities

Application device for a fluid delivery apparatus and method of use

#1157
US20230149626A1
Human necessities

INTRAVENOUS SET DURATION MONITOR

#1158
US20230149627A1
Human necessities

MODULAR INTRAVENOUS ASSEMBLY

#1159 ✅ Patent 12,053,613 granted on 2024-08-06
US20230149628A1
Human necessities

Circular roller clamp assembly

#1160 ✅ Patent 12,194,278 granted on 2025-01-14
US20230149629A1
Human necessities

Injection device and injection solution transferring system

#1161
US20230149630A1
Human necessities

Refill system for medical device using jet delivery principle

#1162
US20230149631A1
Human necessities

PRE-FILLED SYRINGE

#1163
US20230149632A1
Human necessities

AUTO-INJECTOR AND RELATED METHODS OF USE

#1164
US20230149633A1
Human necessities

ELECTROMECHANICAL CAP REMOVER

#1165 ✅ Patent 11,744,955 granted on 2023-09-05
US20230149634A1
Human necessities

Sheath remover and methods for assembly thereof

#1166
US20230149635A1
Human necessities

Applicator for Implant Insertion

#1167 ✅ Patent 12,023,474 granted on 2024-07-02
US20230149636A1
Human necessities

Pen needle hub injection depth optimization

#1168
US20230149637A1
Human necessities

FLUID RESERVOIR CAP WITH GAS TRAPPING FILTER AND ASSOCIATED RETAINING FEATURE

#1169
US20230149638A1
Human necessities

MEDICAMENT DELIVERY DEVICE COMPONENT OR ADD-ON MODULE FOR MEDICAMENT DELIVERY DEVICE

#1170
US20230149639A1
Human necessities

A SYRINGE, A METHOD FOR MANUFACTURING SUCH SYRINGES AND AN ASSEMBLY

#1171
US20230149640A1
Human necessities

SYSTEMS AND METHODS FOR CONDUCTING SMOKE EVACUATION DURING LAPAROSCOPIC SURGICAL PROCEDURES

#1172
US20230149641A1
Human necessities

DRY POWDER INHALATION SYSTEM

#1173
US20230149642A1
Human necessities

INHALER SYSTEMS

#1174 ✅ Patent 12,083,268 granted on 2024-09-10
US20230149643A1
Human necessities

Delivery device and formulation

#1175 ✅ Patent 12,048,805 granted on 2024-07-30
US20230149644A1
Human necessities

Metered dose inhaler add-on device, observance improvement system and method for improving observance of use in metered dose inhalers

#1176 ✅ Patent 11,904,090 granted on 2024-02-20
US20230149645A1
Human necessities

Electronic vaping device

#1177
US20230149646A1
Human necessities

Dual Suction Tube

#1178
US20230149647A1
Human necessities

CUSTOMIZED FACE MASK MADE USING ADDITIVE MANUFACTURE

#1179
US20230149648A1
Human necessities

INFLATABLE HEADGEAR AND PATIENT INTERFACE

#1180
US20230149649A1
Human necessities

SINGLE FLOW AND PRESSURE ACTIVATED AAV

#1181
US20230149650A1
Human necessities

TEXTILE SEAL WITH SILICONE LAYER

#1182 ✅ Patent 11,931,513 granted on 2024-03-19
US20230149651A1
Human necessities

Patient interface

#1183
US20230149652A1
Human necessities

NASAL RESPIRATORY MASK

#1184
US20230149653A1
Human necessities

Nasal Interface Apparatus

#1185
US20230149654A1
Human necessities

A RESPIRATORY CONDUIT

#1186
US20230149655A1
Human necessities

METHODS AND APPARATUS FOR PROVIDING CONCENTRATED THERAPY GAS FOR A RESPIRATORY DISORDER

#1187
US20230149656A1
Human necessities

Electrodes for Nitric Oxide Generation

#1188
US20230149657A1
Human necessities

Ventilator

#1189
US20230149658A1
Human necessities

CONTROL METHOD FOR MEDICAL VENTILATORS

#1190
US20230149659A1
Human necessities

MULTIFUNCTIONAL AROMATHERAPY MACHINE

#1191
US20230149660A1
Human necessities

DEVICE FOR GENERATING SENSORY STIMULATION FOR A CHILD

#1192 ✅ Patent 12,370,341 granted on 2025-07-29
US20230149661A1
Human necessities

PESSARY SYSTEM AND METHOD FOR PELVIC FLOOR LIGAMENT SUPPORT

#1193
US20230149662A1
Human necessities

CATHETER

#1194
US20230149663A1
Human necessities

STEERABLE MEDICAL DEVICE, HANDLE FOR A MEDICAL DEVICE, AND METHOD FOR OPERATING A MEDICAL DEVICE

#1195
US20230149664A1
Human necessities

SHEATH/CATHETER SECURING DEVICE

#1196
US20230149665A1
Human necessities

INTRAVENOUS TUBING SECUREMENT BAND WITH ADJUSTABLE OVERALL LENGTH

#1197 ✅ Patent 11,931,533 granted on 2024-03-19
US20230149666A1
Human necessities

Safety catheter with passive release

#1198
US20230149667A1
Human necessities

Splittable Needle for Catheter Placement System

#1199
US20230149668A1
Human necessities

THREE-DIMENSIONAL PROTECTIVE DEVICE

#1200
US20230149669A1
Human necessities

GUIDEWIRE GUIDE CONFIGURATIONS FOR IMPLANTABLE MEDICAL DEVICES